Search

A recent study conducted at the Catholic University of Korea examined the impact of low skeletal muscle mass on long-term outcomes in patients with liver cancer treated with trans-arterial radioembolization (TARE). The study included 347 patients with hepatocellular carcinoma (HCC) who underwent TARE between 2009 and 2019. The researchers found that low skeletal muscle mass was independently associated with poor overall survival, suggesting that it could be used as a biomarker for identifying TARE candidates. The study concluded that TARE provided favorable long-term outcomes for patients with advanced HCC. [Extracted from the article]